Citigroup
TFFP

Citigroup’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Citigroup’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20
Closed -$3K – 6439
2022
Q2 		$3K Buy
+20
New +$2.79K ﹤0.01% 5815
2022
Q1 		– Sell
-37
Closed -$8K – 6669
2021
Q4 		$8K Hold
37
– – ﹤0.01% 5609
2021
Q3 		$7K Hold
37
– – ﹤0.01% 5558
2021
Q2 		$9K Sell
37
-671
-95% -$184K ﹤0.01% 5717
2021
Q1 		$240K Sell
708
-155
-18% -$63K ﹤0.01% 3922
2020
Q4 		$309K Buy
863
+841
+3,823% +$324K ﹤0.01% 4634
2020
Q3 		$10K Buy
+22
New +$6.21K ﹤0.01% 6653

Other funds holding TFFP

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sepio Capital Salt Lake City, Utah $1.84B AUM 18.57% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Citigroup's TFFP Position: Q3 2022 in Review

Citigroup sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q3 2022, closing a stake of 20 shares — an estimated $3K sold.

Citigroup first reported a position in TFFP in Q3 2020 and held it in 7 quarters. The position peaked at $309K in Q4 2020. 45 funds tracked by Wall St. Rank hold TFFP as of Q3 2022.

  • Citigroup reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Citigroup sold 20 TFF Pharmaceuticals, Inc. Common Stock shares in Q3 2022, an estimated $3K.
  • Citigroup first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
  • Citigroup's TFF Pharmaceuticals, Inc. Common Stock position peaked at $309K in Q4 2020.
  • 45 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.